Study S000920

An Open-lable Trial of Subcutaneous Semaglutide in Systemic Scleroderma

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06149260
Study type: INTERVENTIONAL
Phase: PHASE1
Masking: NONE
Status: UNKNOWN
Enrollment: 10
Start: 2024-02-29
Primary completion: 2024-08-29
Lead sponsor: Second Xiangya Hospital of Central South University
Conditions: Scleroderma, Systemic; Fibrosis; Semaglutide
Interventions: DRUG:Semaglutide Pen Injector
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change in modified Rodnan skin score (mRSS) at week 24 [Baseline and 24 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.